Phase 1 Study of CART-Ddbcma for the Treatment of Subjects with Relapsed and/or Refractory Multiple Myeloma

被引：6

作者：

Frigault, Matthew ^{[1
]}

Rosenblatt, Jacalyn ^{[2
]}

Dhakal, Binod ^{[3
]}

Raje, Noopur ^{[4
]}

Cook, Daniella ^{[5
]}

Gaballa, Mahmoud R. ^{[6
]}

Emmanuel-Alejandro, Estelle ^{[7
]}

Nissen, Danielle ^{[8
]}

Cornwell, Christine ^{[9
]}

Banerjee, Kamalika ^{[9
]}

Rotte, Anand ^{[9
]}

Heery, Christopher R. ^{[9
]}

Avigan, David ^{[10
]}

Jakubowiak, Andrzej ^{[11
]}

Bishop, Michael R. ^{[12
]}

机构：

[1] Massachusetts Gen Hosp, Dorchester, MA USA

[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA

[3] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA

[4] Mass Gen Hosp Canc Ctr, Boston, MA USA

[5] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA

[8] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[9] Arcellx Inc, Gaithersburg, MD USA

[10] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[11] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA

[12] Univ Chicago, David & Etta Jonas Ctr Cellular Therapy, Chicago, IL 60637 USA

来源：

关键词：

D O I：

10.1182/blood-2022-163827

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7439 / 7440

页数：2